Patent details

Basic Information

Publication number:

EP2542224

PCT Application Number:

PCT/EP/2011/052919

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117049965

PCT Publication Number:

WO/2011/107427

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DABIGATRAN ETEXILATE-CONTAINING ORAL PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE À VOIE ORALE CONTENANT D'ÉXILATE DE DABIGATRANE

German Title of Invention:

DABIGATRANEXILAT ENTHALTENDE ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

28/02/2011

Grant date:

13/08/2014

EP Publication Date:

13/08/2014

PCT Publication Date:

09/09/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/01/2013

EP B1 Publication Date:

13/08/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/02/2015

Expiration date:

28/02/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/08/2014

 

 

Name:

ratiopharm GmbH

Address:

Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:

KOEBERLE Martin

Address:

Germany (DE)

2

Name:

STROHMEYER Jutta

Address:

Germany (DE)

3

Name:

PAETZ Jana

Address:

Germany (DE)

4

Name:

BRUECK Sandra

Address:

Germany (DE)

Priority

Priority Number:

10155059

Priority Date:

01/03/2010

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/4184;

Filing date	Document type	Number of pages